Nonparticipation in a population-based trial to increase colorectal cancer screening
- PMID: 22424252
- PMCID: PMC3549634
- DOI: 10.1016/j.amepre.2011.11.014
Nonparticipation in a population-based trial to increase colorectal cancer screening
Abstract
Background: Many trials have tested different strategies to increase colorectal cancer (CRC) screening. Few describe whether participants are representative of the population from which they are recruited.
Purpose: To determine risk factors related to nonparticipation among patients enrolled in an integrated health plan and not up to date for CRC testing, in a trial to increase screening rates.
Methods: Between July 2008 and October 2009, a total of 15,000 adults aged 50-74 years from 21 clinics in Washington State who were due for CRC screening were contacted. Nonparticipants were defined as English-speaking patients who did not engage in the call or refused participation while still potentially eligible. Log-binomial regression models were used to estimate the relative risk of nonparticipation. Analyses were completed between October 2010 and June 2011.
Results: Patients who were nonwhite, had less education, used tobacco, had less continuity of care, and had lower rates of preventive care and cancer screening were more likely to be nonparticipants. Patients reporting never having received any type of CRC testing or screening were also more likely not to participate (62% of nonparticipants vs 46% of participants; adjusted RR=1.58, 95% CI=1.47, 1.70). Reasons for refusal included costs, risks of procedures, and not wanting their medical records reviewed.
Conclusions: Patients eligible for but not participating in the trial were more likely to be from minority socioeconomic and racial groups and had behaviors that can negatively affect cancer outcomes. Additional efforts are needed to recruit patients who need CRC screening the most.
Trial registration: This trial is registered at clinicaltrials.gov NCT 00697047.
Trial registration: ClinicalTrials.gov NCT00697047.
Copyright © 2012 American Journal of Preventive Medicine. All rights reserved.
Similar articles
-
Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test.Eur J Cancer Prev. 2018 Sep;27(5):425-432. doi: 10.1097/CEJ.0000000000000352. Eur J Cancer Prev. 2018. PMID: 28368949
-
Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care.Am J Prev Med. 2014 Mar;46(3):228-36. doi: 10.1016/j.amepre.2013.10.023. Am J Prev Med. 2014. PMID: 24512861
-
Examining the challenges of family recruitment to behavioral intervention trials: factors associated with participation and enrollment in a multi-state colonoscopy intervention trial.Trials. 2013 Apr 30;14:116. doi: 10.1186/1745-6215-14-116. Trials. 2013. PMID: 23782890 Free PMC article. Clinical Trial.
-
Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.JAMA Netw Open. 2019 Dec 2;2(12):e1917995. doi: 10.1001/jamanetworkopen.2019.17995. JAMA Netw Open. 2019. PMID: 31860105 Free PMC article.
-
A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients.BMC Cancer. 2013 Jan 10;13:13. doi: 10.1186/1471-2407-13-13. BMC Cancer. 2013. PMID: 23305355 Free PMC article.
Cited by
-
A Centralized Program with Stepped Support Increases Adherence to Colorectal Cancer Screening Over 9 Years: a Randomized Trial.J Gen Intern Med. 2022 Apr;37(5):1073-1080. doi: 10.1007/s11606-021-06922-2. Epub 2021 May 28. J Gen Intern Med. 2022. PMID: 34047921 Free PMC article. Clinical Trial.
-
Challenges in assessing population reach in a pragmatic trial.Prev Med Rep. 2019 May 29;15:100910. doi: 10.1016/j.pmedr.2019.100910. eCollection 2019 Sep. Prev Med Rep. 2019. PMID: 31198661 Free PMC article.
-
Using a continuum of hybrid effectiveness-implementation studies to put research-tested colorectal screening interventions into practice.Implement Sci. 2019 May 29;14(1):53. doi: 10.1186/s13012-019-0903-5. Implement Sci. 2019. PMID: 31142348 Free PMC article.
-
Time to fecal immunochemical test completion for colorectal cancer screening.Am J Manag Care. 2019 Apr;25(4):174-180. Am J Manag Care. 2019. PMID: 30986014 Free PMC article.
-
A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial.Cancer. 2017 Nov 15;123(22):4472-4480. doi: 10.1002/cncr.30908. Epub 2017 Jul 28. Cancer. 2017. PMID: 28753230 Free PMC article. Clinical Trial.
References
-
- U.S. Preventive Services Task Force. Screening for colorectal cancer: an updated systematic review. Rockville MD: Agency for Healthcare Research and Quality; 2008.
-
- CDC. Vital signs: breast cancer screening among women aged 50–74 years—U.S., 2008. MMWR Morb Mortal Wkly Rep. 2010;59(26):813–816. - PubMed
-
- CDC. Vital signs: colorectal cancer screening, incidence, and mortality—U.S., 2002–2010. MMWR Morb Mortal Wkly Rep. 2011;460(26):884–889. - PubMed
-
- Holden DJ, Harris R, Porterfield DS, et al. Enhancing use and quality of colorectal cancer screening. Rockville MD: Agency for Healthcare Research and Quality; 2010. Report No.: 10-E002.
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
